Brainsway (BRSYF) Non Operating Interest Expenses (2018 - 2026)
Brainsway's (BRSYF) quarterly Non Operating Interest Expenses came in at $879000.0 in Q2 2026, up 12.12% on a YoY basis from $784000.0 in Q2 2025, and up 175.55% quarter-over-quarter from $319000.0 in Q1 2026.
Analysis
Brainsway (BRSYF) Non Operating Interest Expenses (2018 - 2026) Analysis & Trends
Brainsway (BRSYF) has reported Non Operating Interest Expenses for 9 consecutive years, with $879000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Interest Expenses rose 12.12% year-over-year to $879000.0; the trailing twelve-month figure through Jun 2026 stood at $2.2 million (up 5.87% YoY), and the FY2025 full-year result was $2.2 million, up 45.71% from the prior year.
- Non Operating Interest Expenses advanced to $879000.0 in Q2 2026 per BRSYF's latest filing, from $319000.0 in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $2.2 million in Q4 2022 and bottomed at -$329000.0 in Q2 2022.
- Historically, Non Operating Interest Expenses has averaged $455111.1 across 5 years, with a median of $414500.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Non Operating Interest Expenses slumped 63.56% in 2023, then soared 2417.65% in 2024.
- Over 5 years, Non Operating Interest Expenses stood at $2.2 million in 2022, then slumped by 63.56% to $809000.0 in 2023, then tumbled by 58.71% to $334000.0 in 2024, then rose by 29.04% to $431000.0 in 2025, then surged by 103.94% to $879000.0 in 2026.
- According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $879000.0, $319000.0, and $431000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.23 Bn | 175.63 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 127.53 Bn | 122.31 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.08 Bn | 108.26 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 105.08 Bn | 101.60 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 64.51 Bn | 63.97 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.91 Bn | 45.66 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.07 Bn | 31.61 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.35 Bn | 30.40 Bn | 830.00 Mn | - |
| 9 | Steris | 20.78 Bn | 20.30 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn | 879,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 879,000.00 |
| Mar 31, 2026 | 319,000.00 |
| Dec 31, 2025 | 431,000.00 |
| Sep 30, 2025 | 571,000.00 |
| Jun 30, 2025 | 784,000.00 |
| Mar 31, 2025 | 586,000.00 |
| Dec 31, 2024 | 334,000.00 |
| Sep 30, 2024 | 374,000.00 |
| Jun 30, 2024 | 401,000.00 |
| Mar 31, 2024 | 428,000.00 |
| Dec 31, 2023 | 809,000.00 |
| Sep 30, 2023 | 213,000.00 |
| Jun 30, 2023 | 578,000.00 |
| Mar 31, 2023 | 17,000.00 |
| Dec 31, 2022 | 2.22 Mn |
| Sep 30, 2022 | -99,000.00 |
| Jun 30, 2022 | -329,000.00 |
| Mar 31, 2022 | -324,000.00 |
| Dec 31, 2021 | -379,000.00 |
| Sep 30, 2021 | -360,000.00 |